Regular biography
Dr. Andrew M. Lehane is a leading researcher in the field of malaria drug discovery and parasite biology. His work focuses on understanding the molecular mechanisms of drug resistance in *Plasmodium falciparum*, the most deadly malaria parasite, and developing new therapeutic strategies to combat malaria. Dr. Lehane has made significant contributions to the identification of key drug targets, such as the sodium-potassium ATPase (PfATP4) and the lactate transporter (PfFNT), which are critical for the survival and pathogenesis of the parasite. His research has been instrumental in the development of novel antimalarial compounds and the advancement of open-source drug discovery initiatives, such as the Malaria Box. Dr. Lehane is also involved in the study of other parasitic organisms, including *Toxoplasma gondii*, and has explored the role of ion transport and signaling pathways in these pathogens. His work has been published in numerous high-impact journals, and he has received recognition for his contributions to global health and scientific research.